Conceptualizing and measuring modern biotechnology

The Economic Dynamics of Modern Biotechnology

Volumn , Issue , 2004, Pages 20-40

  Brink, Johan ^a   McKelvey, Maureen ^a   Smith, Keith ^b  

^a CHALMERS UNIVERSITY OF TECHNOLOGY   (Sweden)

^b United Nations University INTECH   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84896147032     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.4337/9781845420611.00008     Document Type: Chapter

References (21)

1. Biotechnology Industry Organization (BIO) (2003), website www.bio.org/er/, viewed 30 May 2003.
2. Carlsson, B. (2002), Technological Systems in the Bio Industries: An International Study, Boston and Dordrecht: Kluwer Academic Publishers.
3. Feldman, M.P. and C. Ronzio (2001), 'Closing the innovative loop: moving from the laboratory to the shop floor in biotechnology manufacturing', Entrepreneurship & Regional Development 13, 1-16.
4. Henderson, R., L. Orsenigo and G. Pisano (1999), 'The pharmaceutical industry and the revolution in molecular biology: exploring the interactions between scientific, institutional and organizational change', in D.N. Mowery and R. Cambridge (eds), The Sources of Industrial Advantages, Cambridge: Cambridge University Press.
5. Laage-Hellman, J. (1998), Den biomedicinska industrin i Sverige, Stockholm: NUTEK.
6. Lancaster, K. (1966). 'A new approach to consumer theory', Journal of Political Economy 74(2), 132-57.
7. McKelvey,M. (forthcoming), 'Biotechnology industries', in H. Horst and A. Pyka (eds), Companion on Neo-Schumpeterian Economics, Cheltenham UK and Northampton, USA: Edward Elgar.
8. McKelvey, M., H. Alm and M. Riccaboni (2003), 'Does co-location matter for formal knowledge collaboration in the Swedish biotechnology-pharmaceutical sector?', Research Policy, 32, 483-501.
9. McNiven, C. (2002), 'Use of biotechnologies in the Canadian industrial sector: results from the biotechnology use and development survey - 1999', Statistics Canada working paper, March.
10. McNiven, C., L. Raoub and N. Traoré (2003), 'Features of Canadian biotechnology innovative firms: results from the biotechnology use and development survey - 2001', Statistics Canada working paper, March.
11. Nightingale, P. (2000), 'Economies of scale in experimentation: knowledge and technology in pharmaceutical R&D', Industrial and Corporate Change, 9(2), 315-59.
12. OECD (Organisation for Economic Co-operation and Development) (2001), Biotechnology Statistics in OECD Member Countries: Compendium of Existing National Statistics, Paris: OECD.
13. OECD (2002), Frascati Manual, Paris: OECD.
14. OECD (2003), 'Statistical definition of biotechnology', website www.oecd.org/EN/document/0,,EN-document-617-1-no-21-31006-617,00.html, viewed 20 May 2003.
15. OTA (Office of Technology Assessment) (1984), Commercial Biotechnology: An International Analysis, Washington, DC: US Congress.
16. OTA (1991), Biotechnology in a Global Economy, Washington, DC: US Congress.
17. Payson, S. (2000), Economics, Science and Technology, Cheltenham, UK and Northampton, MA, USA, Edward Elgar.
18. Powell,W.W., K.W. Koput and L. Smith-Doerr (1996), 'Interorganizational collaboration and the locus of innovation: networks of learning in biotechnology, Administrative Science Quarterly, 41(1), 116-45.
19. Sainsbury, Lord (1999), Biotechnology clusters, London: Office of Science and Technology.
20. Swann, P. and M. Prevezer (1996), 'A comparison of the dynamics of industrial clustering in computing and biotechnology', Research Policy, 25, 1139-57.
21. Zucker, L. and M. Darby (1997), 'Present at the biotechnological revolution: transformation of technological identity for a large incumbent pharmaceutical firm', Research Policy, 26, 429-46.